Cargando…
Relative Change in Donor-Derived Cell-free DNA is Superior to Absolute Values for Diagnosis of Acute Lung Allograft Dysfunction
Donor-derived cell-free DNA (dd-cfDNA%) is a biomarker of early acute lung allograft dysfunction (ALAD), with a value of ≥1.0% indicating injury. Whether dd-cfDNA% is a useful biomarker in patients >2 y posttransplant is unknown. Our group previously demonstrated that median dd-cfDNA% in lung rec...
Autores principales: | Trindade, Anil J., Chapin, Kaitlyn C., Gray, Jennifer N., Furuya, Yuka, Mullican, Amy, Hoy, Haley, Demarest, Caitlin T., Robbins, Ivan M., Bacchetta, Matthew, Erasmus, David B., Shaver, Ciara M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212612/ https://www.ncbi.nlm.nih.gov/pubmed/37250487 http://dx.doi.org/10.1097/TXD.0000000000001487 |
Ejemplares similares
-
Assessment of dd-cfDNA Levels in Clinically Stable Lung Allograft Recipients Beyond the Initial 2 y Posttransplant
por: Trindade, Anil J., et al.
Publicado: (2022) -
Surviving White-out: How to Manage Severe Noninfectious Acute Lung Allograft Dysfunction of Unknown Etiology
por: Trindade, Anil J., et al.
Publicado: (2022) -
Pulmonary Allograft Versus Host Disease
por: Dai, David W., et al.
Publicado: (2017) -
The Role of Galectins in Chronic Lung Allograft Dysfunction
por: d’Alessandro, Miriana, et al.
Publicado: (2021) -
Risk of Lung Allograft Dysfunction Associated With Aspergillus Infection
por: Le Pavec, Jérôme, et al.
Publicado: (2021)